Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells $25,875,000.00 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Paul Vigano sold 2,250,000 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $11.50, for a total value of $25,875,000.00. Following the completion of the sale, the insider owned 12,315,892 shares in the company, valued at approximately $141,632,758. This represents a 15.45% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Aveanna Healthcare Stock Performance

AVAH opened at $13.62 on Thursday. Aveanna Healthcare Holdings Inc. has a 12-month low of $5.93 and a 12-month high of $13.98. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47. The firm has a market capitalization of $2.97 billion, a PE ratio of 11.07, a P/E/G ratio of 0.85 and a beta of 1.90. The firm has a 50 day moving average of $9.95 and a two-hundred day moving average of $8.03.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings data on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.17 by $0.05. The business had revenue of $670.48 million for the quarter, compared to the consensus estimate of $638.61 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. On average, analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.75 EPS for the current year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of Aveanna Healthcare during the 2nd quarter worth about $270,000. California State Teachers Retirement System increased its stake in shares of Aveanna Healthcare by 1,351.3% in the 2nd quarter. California State Teachers Retirement System now owns 730,027 shares of the company’s stock valued at $6,256,000 after purchasing an additional 679,727 shares in the last quarter. Braidwell LP raised its holdings in Aveanna Healthcare by 39.1% in the 2nd quarter. Braidwell LP now owns 3,065,106 shares of the company’s stock worth $26,268,000 after purchasing an additional 861,600 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Aveanna Healthcare by 17.6% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 96,956 shares of the company’s stock worth $831,000 after purchasing an additional 14,492 shares in the last quarter. Finally, Littlejohn & Co. LLC purchased a new position in Aveanna Healthcare during the second quarter worth approximately $1,846,878,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on AVAH. Royal Bank Of Canada upped their price target on shares of Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a report on Monday. Truist Financial boosted their price objective on Aveanna Healthcare from $11.00 to $15.00 and gave the company a “hold” rating in a report on Monday. BMO Capital Markets upped their target price on Aveanna Healthcare from $10.00 to $14.00 and gave the stock an “outperform” rating in a research note on Friday, August 14th. Barclays raised their target price on Aveanna Healthcare from $9.00 to $9.50 and gave the stock an “overweight” rating in a report on Thursday, July 9th. Finally, Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $10.00 to $11.00 in a report on Friday, May 15th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $12.89.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.